Here’s why Jim Cramer thinks this market is a ‘buyer’s paradise’
CNBC’s Jim Cramer on Wednesday explained why he thinks this market is favorable for buyers, saying there is…
An unusual suspect is leading Wednesday’s market while the AI trade takes a breather
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
Jim Cramer’s top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Aug. 13 1. AI computing provider CoreWeave’s quarterly results were good,…
Jim Cramer’s top 10 things to watch in the stock market Tuesday
My top 10 things to watch Tuesday, Aug. 12 1. The July consumer price index rose 2.7% on…
Here are the 3 big things we’re watching in the market in the week ahead
Earnings season is winding down, and the market has held up relatively well through the onslaught of quarterly…
Apple’s $704 Billion Decade-Long Buybacks Exceed Market Cap Of All But 13 Companies Worldwide
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Tim…
How a $100 billion pledge helped Wall Street forget about Apple’s AI problems — for now
Nothing like $100 billion to make everyone forget about the AI elephant in the room for Apple. CEO…
Here are 3 stocks that are working in Thursday’s mixed market and another that is not
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
We’re upgrading our rating on Disney thanks to a misguided market reaction to earnings
Disney shares are under pressure Wednesday after the entertainment giant reported mixed quarterly results. We think it’s an…
Jim Cramer’s top 10 things to watch in the stock market Wednesday
My top 10 things to watch Wednesday, Aug. 6 1. Wall Street was heading for a higher open…
S&P 500 struggles to make it two wins in row — plus, a portfolio name leads the M&A race
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
We’re selling more of this health-care stock and wish we could add to another name
We’re selling 50 shares of Abbott Laboratories at roughly $129.66 Following Thursday’s trade, Jim Cramer’s Charitable Trust will…